DELRAY BEACH, Fla. , Sept. 30, 2024 /PRNewswire/ -- The ACL graft market is set to grow from $0.
12 billion in 2024 to $0.18 billion by 2029, with a compound annual growth rate (CAGR) of 7.2%.
This growth is fueled by an aging population more prone to orthopedic issues, as well as increasing healthcare expenditures and expanding healthcare facilities worldwide. The demand for ACL reconstruction procedures is surging, particularly among older adults, with the CDC noting that over 14 million older Americans face annual ACL injury risks, primarily from falls. Despite this, challenges such as surgical risks, inconsistent insurance coverage, and high out-of-pocket costs may hinder market expansion.
The sports injuries segment dominated the market in 2023, driven by rising participation in sports like football and basketball, while North America accounted for the largest market share, supported by advanced surgical techniques and a robust healthcare system. Key players in this market include RTI Surgical and MTF Biologics, with significant growth expected in the Asia Pacific region due to increasing age-related injuries and sports participation..